MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 49 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $275,000 | +1347.4% | 252,968 | +1077.7% | 0.00% | – |
| Q3 2018 | $19,000 | -64.2% | 21,480 | -82.8% | 0.00% | – |
| Q2 2018 | $53,000 | -22.1% | 125,028 | +39.7% | 0.00% | – |
| Q1 2018 | $68,000 | -60.2% | 89,525 | -39.5% | 0.00% | – |
| Q4 2017 | $171,000 | +155.2% | 148,042 | +184.8% | 0.00% | – |
| Q3 2017 | $67,000 | -33.7% | 51,988 | -13.7% | 0.00% | – |
| Q2 2017 | $101,000 | – | 60,239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 10,188,312 | $8,727,000 | 0.75% |
| Vivo Capital, LLC | 6,818,181 | $5,840,000 | 0.55% |
| Stonepine Capital Management, LLC | 668,615 | $573,000 | 0.40% |
| Telemetry Investments, L.L.C. | 574,619 | $492,000 | 0.38% |
| Broadfin Capital, LLC | 766,708 | $657,000 | 0.14% |
| Granite Point Capital Management, L.P. | 1,500,000 | $1,285,000 | 0.09% |
| STALEY CAPITAL ADVISERS INC | 200,000 | $171,000 | 0.01% |
| HYMAN CHARLES D | 79,800 | $68,000 | 0.01% |
| CRA Financial Services, LLC | 10,000 | $9,000 | 0.01% |
| BRIGHTON JONES LLC | 50,000 | $43,000 | 0.01% |